InsiderTrades.com logo

CRDL Insider Trading

Insider Ownership Percentage: 4.57%
Insider Buying (Last 12 Months): C$161,456.47
Insider Selling (Last 12 Months): C$0.00

Cardiol Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Cardiol Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardiol Therapeutics Share Price & Price History

Current Price: C$1.33
Price Change: +0.30 (1.20%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for CRDL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cardiol Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2024Guillermo TorreSenior OfficerBuy17,240C$1.81C$31,277.77
12/19/2024Andrew Warwick HamerSenior OfficerBuy18,900C$1.88C$35,606.69
12/17/2024Bernard LimSenior OfficerBuy10,000C$1.95C$19,500.00
12/16/2024David ElsleyDirectorBuy40,000C$1.88C$75,072.00
6/24/2024David ElsleyDirectorBuy50,000C$2.77C$138,490.00
12/28/2022Guillermo TorreSenior OfficerBuy18,245C$0.52C$9,441.79
See Full Table

SEC Filings (Institutional Ownership Changes) for Cardiol Therapeutics (TSE:CRDL)

1.36% of Cardiol Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Cardiol Therapeutics logo
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.
Read More on Cardiol Therapeutics

Today's Range

Now: C$1.33
Low: C$1.31
High: C$1.37

50 Day Range

MA: C$1.49
Low: C$1.29
High: C$1.72

52 Week Range

Now: C$1.33
Low: C$1.09
High: C$2.17

Volume

59,968 shs

Average Volume

109,150 shs

Market Capitalization

C$133.00 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.305872

Who are the company insiders with the largest holdings of Cardiol Therapeutics?

Cardiol Therapeutics' top insider investors include:
  1. Andrew Warwick Hamer (Senior Officer)
  2. Bernard Lim (Senior Officer)
  3. David Elsley (Director)
  4. Guillermo Torre (Senior Officer)
Learn More about top insider investors at Cardiol Therapeutics.